CancerMPAct

CancerMPact®

A decision-support resource for oncology market analysis, strategic planning, and commercial opportunity analysis.
Get In Touch
CacnerMPact

30+ tumor types in the United States, Western Europe, Japan, and China.

CancerMPact® contains best-in-class cancer epidemiology and proprietary patient calculations for target markets. It is comprised of four web-based modules that cover epidemiology, drug utilization and the current/future treatment landscape for more than 30 tumor types in the United States, Western Europe, Japan, and China. Modules are available individually or as a group by region.

What do you get with CancerMPact®?

Patient Metrics – Core

U.S., Western Europe, Japan, China
  • Epidemiologic data and analysis to estimate incidence (annual new cases of cancer) by stage
  • Restaged 10-year prevalence (annual surviving cancer patients from up to 10 years prior that accounts for progression to later stages)
  • Active disease (estimate of treatment-eligible patients by stage that does not include early-stage patients in remission)
  • Treated patient populations by modality (surgery, radiation, drug therapy, etc.), drug regimens, and drug agents

Patient Metrics – Expanded Markets

Argentina, Brazil, Canada, India, Mexico, Russia, South Korea, Taiwan, and Turkey
  • Combines epidemiologic data and analysis to estimate incidence (annual new cases of cancer) by stage;
  • 5-year prevalence (annual surviving cancer patients from up to five years prior to diagnosis);
  • Treatable patients for 17 tumor types by country for Argentina, Brazil, Canada, India, Mexico, Russia, South Korea, Taiwan, and Turkey.
 

Biomarker Analysis by Patient Metrics

Global resource based on a thorough review of literature and recently published data that discusses the current and evolving oncology landscape with regard to biomarker segmentation and geographic, survival, ethnic, racial, and gender differences.

Treatment Architecture

  • Quantitative analysis of oncology drug utilization across all cancer disease stages, captured for all treatment settings and lines of therapy (by patient type) in tumors where biomarkers have segmented the drug market.
  • Assesses clinical management of cancer patients by site and stage for all treatment modalities, including surgical, radiologic, and systemic agents, as well as untreated patient populations.
  • Provides benchmarks from clinical data to highlight factors contributing to standard-of-care designations.

Future trends and insights

  • Evaluates current and future drug competitors with expert analysis of the competitive landscape and focus on ongoing clinical trials.
  • Explores potential changes in treatment practices in the U.S., Western Europe, and Japan based on evaluations of recently published clinical data, regulatory advances and setbacks, and ongoing clinical trials.
  • Identifies key trends in each tumor market (ex. new product introductions or label expansions).
  • Ascertains and quantifies unmet needs for each cancer while continuously monitoring the pivotal trial landscape.

CancerLandscape™

Web-based platform that allows users to review more than 5,000 clinical cancer drugs simultaneously. It combines multiple data sources so users can assess business development and licensing opportunities, identify novel targets for drug development, compare company pipelines, evaluate new drugs and their mechanisms of action (MOA), and understand the competitive landscape

Thought Leadership by CancerNSight

A central point of oncology thought leadership housing recent webinars, white papers, peer-reviewed publications, infographics and conference vlogs. Access monthly newsletters that highlight the latest news and insights from oncology thought leadership across our company.

Client Results

Global reach

Uncover global cancer patient populations and apply proprietary patient calculations for target markets.

 

Physician decisions

Treatment Architecture offers quantitative analysis of oncology utilization across all cancer disease stages.

Past & future

Our team of experts helps you understand key trends to analyze global markets more quickly, evaluate current and future competitors, and anticipate future events. 

Elevated planning

Our differentiated products and solutions help optimize your commercial opportunities.

Customized

Leverage an expert team of oncology consultants to support your objectives